Current understanding of neuroprotection in glaucoma

Current Opinion in Ophthalmology

Volumn 13, Issue 2, 2002, Pages 61-67

  Wein, Francine B ^a   Levin, Leonard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIZOCILPINE; DOCOSAHEXAENOIC ACID; GLUTARIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIC FACTOR; THROMBIN INHIBITOR; ZINC SULFATE;

CELL DEATH; GLAUCOMA; HUMAN; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW;

CELL DEATH; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 0036201295     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200204000-00002     Document Type: Review

References (66)

1. Characterization of a transformed rat retinal ganglion cell line
2. Animal and culture models of glaucoma for studying neuroprotection
3. Transection of the optic nerve in rats: Studying neuronal death and survival in vivo
4. Morphological and functional analysis of an incomplete CNS fiber tract lesion: Graded crush of the rat optic nerve
5. Retinal ganglion cell and non-neuronal cell responses to a microcrush lesion of adult rat optic nerve
6. Survival of retinal ganglion cells after transection of the optic nerve in adult cats: A quantitative study within two weeks
7. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model
8. Effects of increased intraocular pressure on rat retinal ganglion cells
9. Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice
10. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo
11. Caspase-9: Involvement in secondary death of axotomized rat retinal ganglion cells in vivo
12. Increased expression and activation of poly-(ADP-ribose) polymerase (PARP) contribute to retinal ganglion cell death following rat optic nerve transection
13. Effect of lipid peroxidation inhibition on retinal ganglion cell death
14. Differential susceptibility of retinal ganglion cells to reactive oxygen species
15. RGC death in mice after optic nerve crush injury: Oxidative stress and neuroprotection
16. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection
17. Potential treatment modalities for glaucomatous neuropathy: Neuroprotection and neuroregeneration
18. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells
19. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes
20. Tumor necrosis factor-alpha: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head
21. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells
22. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo
23. Changes in Thy1 gene expression associated with damaged retinal ganglion cells
24. A rat model of chronic pressure-induced optic nerve damage
25. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis
26. TUNEL-positive ganglion cells in human primary open-angle glaucoma
27. In situ detection of apoptosis in normal pressure glaucoma, a preliminary examination
28. Lateral geniculate nucleus in glaucoma
29. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus
30. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma
31. Experimental glaucoma in primates: Changes in cytochrome oxidase blobs in V1 cortex
32. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush
33. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey
34. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells
35. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors
36. Characterization of an N-system amino acid transporter expressed in retina and its involvement in glutamine transport
37. N-acetylated-alpha-linked-acidic dipeptidase inhibitor has a neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia
38. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death
39. Retinal ganglion cell death induced by retinal ischemia, neuroprotective effects of two alpha-2 agonists
40. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure
41. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA
42. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina
43. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage
44. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma
45. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats
46. Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system
47. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury
48. Protective effect of docosahexaenoic acid against retinal ischemic injury: An electroretinographic study
49. Thrombin attenuation is neuroprotective in the injured rat optic nerve
50. Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model
51. Maintaining mitochondrial membrane impermeability, an opportunity for new therapy in glaucoma?
52. Self-protective mechanism awakened by glutamate in retinal ganglion cells
53. Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture
54. Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: Effects of age, caloric restriction, diabetes, pigmentation, and glaucoma
55. Impaired immune and acute-phase responses in interleukin-6-deficient mice
56. Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility
57. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response
58. Vaccination for neuroprotection in the mouse optic nerve: Implications for optic neuropathies
59. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
60. Influences of the glial environment on the elongation of axons after injury: Transplantation studies in adult rodents
61. Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats
62. CNTF promotes the regrowth of retinal ganglion cell axons into murine peripheral nerve grafts
63. Predegenerated peripheral nerve grafts rescue retinal ganglion cells from axotomy-induced death
64. Sustained effects of gene-activated matrices after CNS injury
65. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
66. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study